Aethlon Medical, Inc.

  • Home
  • The Hemopurifier®
    • The Hemopurifier® in Infectious Disease
    • The Hemopurifier® in Cancer
    • Resources
  • About
    • Overview
    • Exosome Sciences, Inc.
    • Executive Team
    • Board of Directors
    • Scientific Advisory Board
    • Contact Us
  • News & Media
    • Press Releases
    • Presentations
    • Events
    • Outside Media
  • Investors
    • Overview
    • Corporate News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
    • IRS Form 8937
News & Media

News & Media

  • Press Releases
  • Presentations
  • Events
  • Outside Media

Press Releases

Sep 18, 2018

Aethlon Medical Receives National Cancer Institute Award

Aug 8, 2018

Aethlon Medical Announces First Quarter Fiscal Year 2019 Results

Aug 2, 2018

Aethlon Medical To Release Financial Results for the First Quarter Fiscal Year 2019 and Host Conference Call on August 8, 2018

Jul 23, 2018

Aethlon Medical Announces Issuance of Hemopurifier® Patent To Treat Life-Threatening Viruses

Jun 25, 2018

Guy Cipriani Joins Aethlon Medical's Board of Directors

Jun 8, 2018

Aethlon Medical Announces Fiscal 2018 Results

May 31, 2018

Aethlon Medical To Release 2018 Fiscal Year End Financial Results and Host Conference Call on June 8, 2018

Mar 22, 2018

Study of Blood Test to Detect and Monitor Chronic Traumatic Encephalopathy (CTE) in Former NFL Players Set for Kick-Off in Phoenix

Feb 12, 2018

Aethlon Medical To Present at the American Society for Microbiology Biothreats Meeting

Feb 1, 2018

Aethlon Medical Announces Fiscal 2018 Third Quarter Results

    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...19
    • Facebook
    • Twitter
    • Linkedin
    • YouTube
    Privacy Policy Disclaimer Sitemap
    © 2021 Aethlon Medical, Inc. All Rights Reserved.